|
Cancer therapies and diagnostics – from new technologies to enhanced biotech and
drug developments, to the consumer market for genetic testing – will be at the center
of Cleveland Clinic’s 7th Annual Medical Innovation Summit.
The summit will bring together 900 leaders from throughout the healthcare industry to
learn about the latest innovations in cancer therapy, diagnostics and management.
Attendees will have the opportunity to gain an in-depth view of the innovation process,
hear decision makers’ views of the sector, learn more about the current market, and
explore future directions for medical innovation.
Drawing international CEOs, leading venture capitalist, entrepreneurs, renowned physicians
and top technologists, the summit will examine in detail the hottest new technologies,
prospects for new innovation, and forces shaping the markets for new medical technology.
Distinguished speakers include: CEOs Sam Palmisano, IBM; Daniel Vasella MD, Novartis;
David Brennan, AstraZeneca; Fred Hassan, Schering-Plough; Richard Clark, Merck; Greg Lucier,
Life Technologies; FDA Commissioner Margaret Hamburg; and network correspondent
Maria Bartiromo.
View our flash presentation:
Return to Current Issue
|
